HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor.

Abstract
DALCE (1-40 micrograms, ICV), a short-acting agonist and long-acting antagonist at the delta opioid receptor, was examined for its effects upon food intake in rats under spontaneous, deprivation, glucoprivic and palatable conditions. DALCE (10 micrograms) significantly stimulated free feeding for up to 10 h but only minimally decreased (40 micrograms) food intake and body weight after 24-72 h. DALCE, administered prior to food deprivation (24 h), failed to affect subsequent 24-h intake and sporadically decreased intake and body weight change after 48-72 h. 2-Deoxy-D-glucose (650 mg/kg, IP) hyperphagia was transiently (2 h) decreased by long-term DALCE (10 micrograms) pretreatment. Hyperphagia following exposure to a high-fat diet was significantly potentiated by long-term DALCE (1 microgram) pretreatment. DALCE (10 micrograms) hyperphagia (2-10 h) was eliminated by central pretreatment with either naltrexone (20 micrograms) or the kappa antagonist, nor-binaltorphamine (20 micrograms) but was minimally affected by central pretreatment with the mu antagonist, beta-funaltrexamine (20 micrograms) or long-term DALCE (40 micrograms). The general inability of the antagonist actions of DALCE to alter these forms of feeding argues against a role for the delta opioid receptor in these responses.
AuthorsD Arjune, W D Bowen, R J Bodnar
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 39 Issue 2 Pg. 429-36 (Jun 1991) ISSN: 0091-3057 [Print] UNITED STATES
PMID1658817 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Dietary Fats
  • Narcotic Antagonists
  • Receptors, Opioid, delta
  • norbinaltorphimine
  • enkephalin-Leu, Ala(2)-Cys(6)-
  • Naltrexone
  • Enkephalin, Leucine-2-Alanine
  • beta-funaltrexamine
  • Deoxyglucose
  • Glucose
Topics
  • Animals
  • Deoxyglucose (pharmacology)
  • Diet
  • Dietary Fats (pharmacology)
  • Dose-Response Relationship, Drug
  • Enkephalin, Leucine-2-Alanine (administration & dosage, analogs & derivatives, antagonists & inhibitors, pharmacology)
  • Feeding Behavior (drug effects)
  • Food Deprivation
  • Glucose (pharmacology)
  • Injections, Intraventricular
  • Male
  • Naltrexone (analogs & derivatives, pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid, delta

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: